The Ministry of Science and Technology expects that based on the results of the research, the project team may propose the use of lopinavir and ritonavir in treating nCoV patients.
A combination of lopinavir/ritonavir for the treatment and prevention of HIV/AIDS will be used on trial basis for the treatment of new coronavirus (nCoV) patients in Vietnam, Tuoi Tre Online reported.
In order to develop a new treatment regimen for nCoV patients, the Minister of Science and Technology Chu Ngoc Anh has approved the project to assess the effectiveness and safety of lopinavir/ritonavir supplementation in the treatment of nCoV patients.
Hospitals, enterprises in Vietnam ensure enough medicines for nCoV treatment. Photo: Duong Ngoc |
Lopinavir/ritonavir is known as a fixed dose combination formulation for treating and preventing HIV/AIDS infection.
The scientists in the research group will test in four weeks or more on ten patients. Then, they will report on the effectiveness of clinical, subclinical, and virological responses evaluation as well as the safety of lopinavir/ritonavir use in treating nCoV patients who are under the Ministry of Health’s background treatment regimen.
The Ministry of Science and Technology expects that based on the results of the research, the project team may propose the use of lopinavir and ritonavir in treating nCoV patients.
Vietnam is conducting research on producing nCoV vaccine
Deputy Minister of Health Nguyen Thanh Long said at a meeting on February 10 that there are currently about 22 units nationwide testing and carrying out research on the production of an nCoV vaccine, Zing reported.
In the mean time, the Ministry of Health also welcomes and encourages all scientific and technological units to engage in biological products and testing equipment production, Long added.
However, the deputy minister said producing preventive vaccine, especially against a new strain of virus, is not easy.
Earlier, on February 7, Vietnam’s National Institute of Hygiene and Epidemiology under the Ministry of Health announced that it has successfully isolated and grown new coronaviruses in the laboratory.
The successful cultivation of nCoV is the basis for future research and development of a vaccine against the virus and provides more effective preventive measures.
The institute said that this successful cultivation will enable rapid testing of nCoV infections and suspected cases. As a result, Vietnam is capable of testing thousands of specimens every day if necessary.
Currently, Vietnam has more than 1,000 people returning from China. Nearly 500 people making close contact with people infected with nCoV are isolated, monitored and tested.
According to the Ministry of Health, up to now, Vietnam still ensures sufficient biological products for testing.
Other News
- PM urges Vietnamese adults to donate organs
- WHO official praises Vietnam's health performance
- Millions of children in Vietnam protected by vaccination over 40 years: UN agencies
- Hanoi accelerating efforts to reduce new tuberculosis cases
- Hanoi aims for 94.5% health insurance coverage this year.
- Denmark helps Vietnam enhance primary health care
- Hanoi hospitals to ensure quality healthcare during Tet
- Vietnamese doctors master single-port endoscopy
- EU Green Education: Significant to biodiversity protection in Vietnam
- Health sector joins efforts against climate change
Trending
-
Vietnamese parliament elects Tran Thanh Man as new chairman
-
Vietnam news in brief - May 20
-
PM urges Vietnamese adults to donate organs
-
Japanese duo of illusionists to wow audiences in Vietnam
-
Construction begins on expansion of Noi Bai Airport
-
Hanoi's 70th liberation anniversary literary and art contest launched
-
Walking tour to experience public arts in the heart of Hanoi
-
Propaganda poster contests launched for Hanoi’s 70th liberation anniversary
-
Bas-reliefs on Hue's nine dynastic urns listed as UNESCO heritage